Suppr超能文献

肾移植术后次日起使用低剂量类固醇的优势。

Advantages of low dose steroid from the day after renal transplantation.

作者信息

McGeown M G, Douglas J F, Brown W A, Donaldson R A, Kennedy J A, Loughridge W G, Mehta S, Nelson S D, Doherty C C, Johnstone R, Todd G, Hill C M

出版信息

Transplantation. 1980 Apr;29(4):287-89. doi: 10.1097/00007890-198004000-00005.

Abstract

We have used a low dose of steroid (20 mg of prednisolone), commencing the day after transplantation, for 151 consecutive renal transplants in 141 patients. Five patients received grafts from living related donors, 146 received cadaver grafts. All patients received azathioprine for routine immunosuppression and the first 47 received a single dose of actinomycin C i.v. for treatment of rejection. No other immunosuppressive drugs were used. This treatment provided satisfactory immunosuppression as 109 of 151 grafts continue to function for periods of 3 months to 10 years and, of 42 grafts lost, only 17 failed from rejection. The cumulative survival of first cadaver grafts at 1 and 2 years in recipients of all ages (7 to 55 years) was 77.9 and 76.0%, respectively; in recipients 15 to 34 years old, 90.9 and 86.1%, respectively. Twenty-three patients died, no patient died from infection during the admission for transplantation, and infection played a part in the deaths of only four patients. The incidence of other complications was low; seven patients developed gastrointestinal complications, one died, four patients developed diabetes, all survived; only one patient developed avascular necrosis of bone.

摘要

我们对141例患者的151例肾移植连续使用了低剂量类固醇(20毫克泼尼松龙),于移植后次日开始用药。5例患者接受了亲属活体供肾移植,146例接受了尸体供肾移植。所有患者均接受硫唑嘌呤进行常规免疫抑制,前47例患者静脉注射单剂量放线菌素C用于治疗排斥反应。未使用其他免疫抑制药物。这种治疗提供了令人满意的免疫抑制效果,151例移植肾中有109例在3个月至10年的时间内持续发挥功能,在42例失功的移植肾中,只有17例因排斥反应失败。所有年龄(7至55岁)受者首次尸体供肾移植在1年和2年时的累积生存率分别为77.9%和76.0%;15至34岁受者的累积生存率分别为90.9%和86.1%。23例患者死亡,移植住院期间无患者死于感染,只有4例患者的死亡与感染有关。其他并发症的发生率较低;7例患者出现胃肠道并发症,1例死亡,4例患者患糖尿病,均存活;只有1例患者发生骨缺血性坏死。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验